[Restenosis in a cobalt-chromium stent 36 months after implantation into the right coronary artery].

Kardiol Pol

Katedra i Klinika Kardiologii i Chorób Wewnetrznych, Collegium Medicum im. L. Rydygiera Bydgoszcz, Uniwersytet Mikołaja Kopernika, Toruń.

Published: September 2008

Download full-text PDF

Source

Publication Analysis

Top Keywords

[restenosis cobalt-chromium
4
cobalt-chromium stent
4
stent months
4
months implantation
4
implantation coronary
4
coronary artery]
4
[restenosis
1
stent
1
months
1
implantation
1

Similar Publications

Iliac artery angioplasty with stenting is an effective alternative treatment modality for aortoiliac occlusive diseases. Few randomized controlled trials have compared the efficacy and safety between self-expandable stent (SES) and balloon-expandable stent (BES) in atherosclerotic iliac artery disease. In this randomized, multicenter study, patients with common or external iliac artery occlusive disease were randomly assigned in a 1:1 ratio to either BES or SES.

View Article and Find Full Text PDF

Iron is considered as an attractive alternative material for bioresorbable scaffolds (BRS). The sirolimus eluting iron bioresorbable scaffold (IBS), developed by Biotyx Medical (Shenzhen, China), is the only iron-based BRS with an ultrathin-wall design. The study aims to investigate the long-term efficacy, safety, biocompatibility, and lumen changes during the biodegradation process of the IBS in a porcine model.

View Article and Find Full Text PDF

Large vessel stenosis is currently successfully treated with percutaneous stent implantation. Zephyr stent is a cobalt-chromium peripheral stent specifically designed for large-vessel stenting. Its specific "S-" and "C-" shaped flexible polylinks prevent stent foreshortening and recoil.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical events can occur after percutaneous coronary intervention (PCI), especially in complex cases, and using advanced intracoronary imaging and pressure guidewires may help reduce these risks.
  • The OPTI-XIENCE study is an international, multicenter prospective observational study involving 1,064 patients with specific high-risk characteristics undergoing stent implantation, monitoring them for 12 months.
  • The study aims to evaluate the effectiveness of using these intracoronary tools, with the primary focus on the rate of target lesion failure after one year, while also assessing additional cardiovascular outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!